SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 17.14
-0.08 (-0.46%)
Oct 13, 2026, 11:13 AM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 959.81 million as of October 12, 2026. It is the 25,660th most valuable company in the world and the 313th biggest in Sweden. Its market cap has decreased by 27.87% in one year.
Market Cap
959.81M
Enterprise Value
946.51M
Revenue
n/a
Global Rank
Country Rank
#313 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 959.81M, an increase of 1,405.54%. That is a compound annual growth rate of 30.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 959.81M | -20.37% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioInvent International AB | 1.53B |
| Genovis AB (publ.) | 1.37B |
| Saniona AB | 1.32B |
| Flerie AB | 1.32B |
| Oncopeptides AB | 1.17B |
| Infant Bacterial Therapeutics AB | 975.33M |
| Medivir AB | 932.31M |
| AlzeCure Pharma AB | 932.19M |